Name: dv new pitch deck condensed
Uploaded: 2025-09-26
Duration: 3 min 55 s
Description: Mission Protect Human Health and Agriculture in the US and World.

Mission Protect Human Health and Agriculture in the US and World. 

Scene 1

Mission Protect Human Health and Agriculture in the US and World

Goal Strengthen host protein machinery to develop effective, safe, and affordable treatments for bacterial and viral diseases in humans and plants

Problem: Plant Diseases Posing Threats to Agriculture. 

Scene 2

Problem: Plant Diseases Posing Threats to Agriculture

Scene 3

SARS-CoV-2 ACE2 binding to the spike protein ACE2 Lung Cell Viral Replication ...J Spike Protein. 

Scene 4

SARS-CoV-2
ACE2 binding to the
spike protein
ACE2
Lung Cell
Viral Replication ...J
Spike
Protein

SARS-CoV-2 ACE2 binding to the spike protein ACE2 Lung Cell Viral Replication Spike Protein. 

Scene 5

SARS-CoV-2
ACE2 binding to the
spike protein
ACE2
Lung Cell
Viral Replication
Spike
Protein

Solutions: A Novel COVID-19 Treatment Effective on All Virus Variants

What we do? Deliver a protein chimera that blocks the first step in the infection cycle and clears SARS-CoV-2 from the lung

How does it work? Exosome-like vesicles are constructed using biocompatible lipid mixtures. These vesicles are encapsulated with a plasmid bearing the chimera gene and surface coated with cell penetrating peptides. Upon exosome inhalation, the chimera is delivered to the lung wherein the ACE2 mimic region of the chimera binds the spike protein of the virus and the bound virus is cleared by the Fc domain of the chimera.

Source - https://www.marketsandmarkets.com/Market-Reports/plant-biotechnology-market-225105561. 

Scene 6

Source - https://www.marketsandmarkets.com/Market-Reports/plant-biotechnology-market-225105561

CAGR 8.2% Market Size (US$B) by Regions Market Share (%) by Products Key Players Projected Market Share of Our Product

The Landscape Our antibacterial protein chimera may only access 10% of the market, which include the treatments of vector-borne plant diseases, such as HLB in citrus and PD in grapevines. Our treatment offers a better alternative than insecticides and antibiotics. While GM seeds (offered by big pharma) may provide a long-term disease resistance, it is time-consuming, expensive process, and unpopular to the consumers.
 The Traction of Our Product The non-GMO approach ensures that our treatment is as effective as the GM products but is achieved in months not in 15 years. Although ours is a novel treatment, all the R&D studies are completed and the future optimization steps have been planned to increase the efficacy of treatment and lower the cost.

Source - https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184. 

Scene 7

Source - https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184

MarketsandMarkets Logos 
 Market Size (US$B) by Drug Class Usage by Drug Class Key Players Projected Market Share of Our Product

The Landscape Currently, steroid-based and antiviral (small molecule, RNAi) drugs occupy over 50% of the COVID-19 market. The biologics (such as ours) occupy the rest of the market, wherein at present big pharma provide recombinant proteins and monoclonal antibodies with proven activity (i.e., requiring no additional R&D). 
 The Traction of Our Product Our product, ACE2Mimic-Fc chimera, is effective against all SARS-COV-2 variant unlike the drugs and vaccines in the market. The chimera is delivered as a gene (rather than a recombinant protein), which makes the cost of treatment lower than that of the current ones. Use of exosome-like particles as the gene delivery system ensures that the treatment is effective and safe.

Scene 8

Website: Diverse Vitality https://www.diversevitality.com. 

Scene 9

Website: Diverse Vitality https://www.diversevitality.com

For company  organization, leadership, legal, and financial team, check the website.

dv new pitch deck condensed

slide7-hotlinkundefined

MarketsandMarkets Logos 
 Market Size (US$B) by Drug Class Usage by Drug Class Key Players Projected Market Share of Our Product





slide7-hotlink30

 Website: Diverse Vitality https://www.diversevitality.com


dv new pitch deck condensed

Scene 1 (0s)

Scene 2 (17s)

Scene 3 (28s)

Scene 4 (38s)

Scene 5 (51s)

Scene 6 (1m 32s)

Scene 7 (2m 31s)

Scene 8 (3m 29s)

Scene 9 (3m 38s)